From Inquiry To Insight Dr Michael Strong вђ Als Society Of Canada – dr. michael strong, arthur j. hudson chair in als research at schulich school of medicine & dentistry. als, also known as lou gehrig’s disease, is a debilitating neurodegenerative condition that progressively impairs nerve cells responsible for muscle control, leading to muscle wastage, paralysis and, ultimately, death. My clinical research focuses on understanding the natural history of als, and in particular the occurrence of “non motor” manifestations of the disease. most prominent amongst these are the findings of frontotemporal dysfunction, manifested as a behavioural syndrome, a dysexecutive syndrome, a cognitive syndrome or a florid frontotemporal.
Als Researcher Michael Strong Youtube The temerty foundation is investing $10 million over five years to help translate dr. michael strong’s promising als research into a potential treatment for patients. the temerty foundation was established by james temerty (centre), founder of northland power inc., and louise arcand temerty. In a groundbreaking canadian discovery powered by philanthropy, a team of western university researchers led by dr. michael strong has uncovered a potential path toward a cure for amyotrophic lateral sclerosis (als). the breakthrough, which illustrates how protein interactions can preserve or prevent the nerve cell death that is a hallmark of. Dr. michael strong, arthur j. hudson chair in als research at western's schulich school of medicine & dentistry, has discovered a protein that could lead to a treatment for als. In a groundbreaking canadian discovery powered by philanthropy, a team of western university researchers led by dr. michael strong has uncovered a potential path toward a cure for amyotrophic.
Comments are closed.